Axsome Therapeutics, Inc. (AXSM)
Market Closed
16 Oct, 08:00 PM
$
157. 14
-4.65
-2.8741%
$
8.23B Market Cap
- P/E Ratio
- Div Yield
537,633 Volume
-4.27 Eps
$ 161.79
Previous Close 
Want to track AXSM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Axsome Therapeutics, Inc. (AXSM) Statistics
Valuation metrics
Market Cap 8.23B
Enterprise value 8.13B
Trailing P/E (ttm) -41.9
Forward P/E 29.89
PEG ratio -1.47
Price/Sales (ttm) 10.6
Price/Book (mrq) 97.15
Enterprise Value/Revenue 10.47
Enterprise Value/EBITDA -46.16
Overview
Shares outstanding 50.88M
Float 43.24M
Shares short 2.83M
% Held by insiders 0.15%
% Held by institutions 0.76%
Average volume (10 days) 926.99K
Average volume (90 days) 727.43K
Price summary
52-Week low 123.5
52-Week high 260.19
Beta 0.47
50-Day moving average 191.87
200-Day moving average 212.7
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -0.25%
Operating margin -0.24%
Operational effectiveness
Return on assets -0.25%
Return on equity -2.56%
Income Statement
Revenue (ttm) 638.5M
Revenue per share (ttm) 15.08
Quarterly revenue growth (yoy) 0.65%
Gross profit (ttm) 591.02M
EBITDA -160.17M
Net income to common (ttm) -183.17M
Diluted EPS (ttm) -3.72
Quarterly earnings growth (yoy) 0.65%
Balance Sheet
Total cash (mrq) 322.93M
Total cash per share (mrq) 6.21
Total debt (mrq) 218.11M
Total Debt/Equity (mrq) 2.63
Current ratio (mrq) 1.43%
Book value per share (mrq) 1.62
Cash Flow
Cash flow statement -93.41M
Levered free cash flow (LFCF) -29.42M
2026 © Marketlog. All Rights Reserved.
